❗️ EMA has started evaluating a marketing authorisation application for Bimervax, the #COVID19vaccine developed by HIPRA.

Check out our latest updates on the #COVID19 pandemic: https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates

🐦🔗: https://n.respublicae.eu/EMA_News/status/1638470687554695168